XPF-001 + placebo
Phase 2Completed 0 watching 0 views this week⚡ Active
49
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Dental Pain
Conditions
Dental Pain
Trial Timeline
Sep 1, 2009 → Dec 1, 2009
NCT ID
NCT00954356About XPF-001 + placebo
XPF-001 + placebo is a phase 2 stage product being developed by Xenon Pharmaceuticals for Dental Pain. The current trial status is completed. This product is registered under clinical trial identifier NCT00954356. Target conditions include Dental Pain.
Hype Score Breakdown
Clinical
17
Activity
12
Company
7
Novelty
5
Community
5
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01090622 | Phase 1/2 | Completed |
| NCT00954356 | Phase 2 | Completed |
Competing Products
20 competing products in Dental Pain